Show simple item record

dc.contributor.authorErl, W
dc.contributor.authorWeber, C
dc.contributor.authorZernecke, A
dc.contributor.authorNeuzil, J
dc.contributor.authorVosseler, CA
dc.contributor.authorKim, HJ
dc.contributor.authorWeber, PC
dc.contributor.editorLise Leclercq Reth [Editor-in-Chief]
dc.date.accessioned2017-05-03T12:22:15Z
dc.date.available2017-05-03T12:22:15Z
dc.date.issued2004
dc.date.modified2009-09-08T08:03:40Z
dc.identifier.issn0014-2980
dc.identifier.doi10.1002/eji.200324053
dc.identifier.urihttp://hdl.handle.net/10072/5682
dc.description.abstractCyclopentenone prostaglandins (CP-PG), such as prostaglandin A1 (PGA1) or 15-deoxy-12,14-prostaglandin J2 (PGJ2), induce apoptosis in different cell types. PGJ2 is also a potent activator of the peroxisome proliferator-activated receptor- (PPAR). We investigated whether PPAR regulates CP-PG-induced apoptosis in endothelial cells (EC). We show that CP-PG induce apoptosis in human umbilical vein EC (HUVEC). Incubation with PGA1 or PGJ2 for 24 h reduced HUVEC number and viability, while the synthetic activators Wy14643 or rosiglitazone had no effect. Flow cytometry and cell cycle analysis revealed externalized phosphatidylserine, caspase-3 activation, and an increased percentage of cellswith a reduced DNA content by CP-PG treatment. EMSA demonstrated an activation of PPAR by PGJ2 and rosiglitazone. Immunohistochemistry of HUVEC and immunoblot analyses of protein extracts showed that PPAR was localized in the nuclei of HUVEC, and that CP-PG treatment decreased the amount of PPAR protein. This degradation was prevented by a pan-caspase inhibitor. Treatment of differentiated, endothelial-like PPAR-deficient stem cells, or of HUVEC transfected with dominant-negative PPAR with CP-PG, induced cell death and apoptosis. Our findings show that PGA1 and PGJ2 induce apoptosis in endothelial cells independent of PPAR. As the synthesis of PGJ2 is increased at sites of inflammation, our results may suggest a possiblemechanism for endothelial damage.
dc.description.peerreviewedYes
dc.description.publicationstatusYes
dc.languageEnglish
dc.language.isoeng
dc.publisherWiley - V C H Verlag GmbH & Co. KGaA
dc.publisher.placeGermany
dc.publisher.urihttps://onlinelibrary.wiley.com/doi/full/10.1002/eji.200324053
dc.relation.ispartofpagefrom241
dc.relation.ispartofpageto250
dc.relation.ispartofjournalEuropean Journal of Immunology
dc.relation.ispartofvolume34
dc.subject.fieldofresearchImmunology
dc.subject.fieldofresearchcode3204
dc.titleCyclopentanone prostaglandins induce endothelial cell apoptosis independent of peroxisome proliferator activated receptor-γ
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
gro.rights.copyright© 2004 John Wiley & Sons, Ltd. Self-archiving of the author-manuscript version is not yet supported by this publisher. Please refer to the journal link for access to the definitive, published version or contact the author for more information.
gro.date.issued2004
gro.hasfulltextNo Full Text
gro.griffith.authorNeuzil, Jiri


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record